Breast cancer shows an extremely high incidence affecting more than 5 millions women yearly worldwide. As of January 2019 there are 16.9 million cancer survivors in the United States alone (5% of the population) and the increasing rate of long-term survivors is leading to a paradigm-shift in their clinical management. To date, quality-of-life issues are becoming more and more prominent in clinical decision-making and clinical trial design. However, quality of life is a subjective phenomenon and there is no consensus on definitions and improvement strategies.
This Research Topic will focus on issues and complications affecting quality of life in breast cancer survivors, addressing all the specific physical and psychosocial domains involved and the more advanced treatment options. We would like to provide a monographic portrait of the current state of knowledge and forthcoming clinical perspectives about the quality of life in breast cancer patients and survivors, particularly in terms of biomarker discovery, conservative surgical interventions, drug toxicity management, rehabilitation, and communication.
We welcome Original Research and Review articles describing results of clinical studies, translational research as well as basic science with a strong focus on the quality of life in breast cancer survivors. Potential topics include but are not limited to the following:
1) Complications and side effects related to surgery, radiotherapy (eg. Lymphedema) and systemic therapy (eg. Alopecia, sensory changes)
2) Cancer related fatigue, Pain, Sleep disorders, Psychosocial problems and Cardiovascular disorders
3) Tumor progression and secondary cancers
4) Physical activity and exercise
5) Pregnancy and breastfeeding in breast cancer patients and survivors: Oncologic safety and fetal/child outcomes
6) Psychosocial issues in breast cancer survivors: needs and expectations in breast cancer patients
7) Return to social and professional life after breast cancer diagnosis
8) Complementary and Integrative medicine interventions
9) Rehabilitation and quality of life
10) New biomarkers related to improved quality of life after treatment
Breast cancer shows an extremely high incidence affecting more than 5 millions women yearly worldwide. As of January 2019 there are 16.9 million cancer survivors in the United States alone (5% of the population) and the increasing rate of long-term survivors is leading to a paradigm-shift in their clinical management. To date, quality-of-life issues are becoming more and more prominent in clinical decision-making and clinical trial design. However, quality of life is a subjective phenomenon and there is no consensus on definitions and improvement strategies.
This Research Topic will focus on issues and complications affecting quality of life in breast cancer survivors, addressing all the specific physical and psychosocial domains involved and the more advanced treatment options. We would like to provide a monographic portrait of the current state of knowledge and forthcoming clinical perspectives about the quality of life in breast cancer patients and survivors, particularly in terms of biomarker discovery, conservative surgical interventions, drug toxicity management, rehabilitation, and communication.
We welcome Original Research and Review articles describing results of clinical studies, translational research as well as basic science with a strong focus on the quality of life in breast cancer survivors. Potential topics include but are not limited to the following:
1) Complications and side effects related to surgery, radiotherapy (eg. Lymphedema) and systemic therapy (eg. Alopecia, sensory changes)
2) Cancer related fatigue, Pain, Sleep disorders, Psychosocial problems and Cardiovascular disorders
3) Tumor progression and secondary cancers
4) Physical activity and exercise
5) Pregnancy and breastfeeding in breast cancer patients and survivors: Oncologic safety and fetal/child outcomes
6) Psychosocial issues in breast cancer survivors: needs and expectations in breast cancer patients
7) Return to social and professional life after breast cancer diagnosis
8) Complementary and Integrative medicine interventions
9) Rehabilitation and quality of life
10) New biomarkers related to improved quality of life after treatment
